Ignite Creation Date:
2024-05-06 @ 12:38 AM
Last Modification Date:
2024-10-26 @ 10:52 AM
Study NCT ID:
NCT01625234
Status:
COMPLETED
Last Update Posted:
2021-10-06
First Post:
2012-06-15
Brief Title:
Phase 12 Study of X-396 an Oral ALK Inhibitor in Patients With ALK-positive Non-Small Cell Lung Cancer
Sponsor:
Xcovery Holdings Inc
Organization:
Xcovery Holdings Inc